This compound is primarily used in medicinal chemistry and pharmaceutical research as an intermediate in the synthesis of more complex molecules. Its structure, featuring a cyclopropyl group, a 2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl moiety, and a urea functional group, makes it valuable in the development of targeted therapies, particularly in the field of cancer treatment. The boronic ester group is often utilized in Suzuki-Miyaura cross-coupling reactions, a key method for forming carbon-carbon bonds in drug discovery. Additionally, the presence of the urea functional group can contribute to the compound's ability to interact with biological targets, such as enzymes or receptors, making it a potential candidate for the design of enzyme inhibitors or receptor modulators. Its applications are mainly focused on preclinical research for identifying and optimizing new therapeutic agents.